CSI Market
Sign In | Register

Belite Bio Inc (BLTE) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BLTE Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Belite Bio Inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		0 0 0 (Dec 31 2024)
Operating Activities
Income-77.61
Depreciation & amortization0.17
Amortization of Other Assets0.01
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation38.92
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Operating Lease Right Of Use Asset Amortization Expense-
Interest Income From Investment-
Operating Lease Payments-
Operating Lease Payments-
Income taxes8.09
Unrealized Gain (Loss) on Investments0.00
Increase (Decrease) in Other Receivables0.07
Increase (Decrease) in Due to Related Parties, Total-0.01
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities3.85
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.15
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.30
Discontinued operations0.00
Net Cash flow from Operating Activities-36.99
Investing Activities
Capital Expenditures0.07
Sale of Capital Items0.00
Short-term Investments Proceeds4.50
Payments to Acquire Held-to-maturity Securities451.99
Real Estate Investments0.00
Prepayments To Acquire Property Plant And Equipment-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale, Maturity and Collection of Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-305.11
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock7.85
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net552.40
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities663.23
Effect of exchange rate on cash flow0.12
Discontinued operations0.00
Free Cash Flow-36.92
Total Cash Flow321.26
4 historic quarters locked

Sign in to unlock the full Belite Bio Inc cash flow history.

Sign In Create Free Account

About Belite Bio Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-037374

Figures are derived from filed reports and may be restated. Historical data is subject to revision.